Edition:
United States

AtriCure Inc (ATRC.OQ)

ATRC.OQ on NASDAQ Stock Exchange Global Market

18.38USD
4:00pm EDT
Change (% chg)

$-0.10 (-0.54%)
Prev Close
$18.48
Open
$18.45
Day's High
$18.45
Day's Low
$18.12
Volume
50,819
Avg. Vol
87,357
52-wk High
$20.36
52-wk Low
$13.44

Latest Key Developments (Source: Significant Developments)

Atricure Q4 loss per share $0.27
Tuesday, 28 Feb 2017 04:03pm EST 

Atricure Inc : Atricure reports fourth quarter and full year 2016 financial results . Q4 revenue $41.2 million versus I/B/E/S view $42 million . Sees FY 2017 loss per share $0.94 to $1.04 . Q4 loss per share $0.27 . Sees FY 2017 revenue up about 13 to 15 percent . Q4 earnings per share view $-0.31 -- Thomson Reuters I/B/E/S . FY 2017 earnings per share view $-0.87, revenue view $177.6 million -- Thomson Reuters I/B/E/S .Atricure Inc - continues to expect positive adjusted ebitda for full year 2018.  Full Article

AtriCure announces preliminary results for Q4 and FY 2016
Monday, 9 Jan 2017 08:00am EST 

AtriCure : AtriCure announces preliminary results for fourth quarter and full year 2016 . Sees FY 2017 loss per share $0.88 to $0.96 . Sees FY 2017 revenue up about 13 to 15 percent . Sees FY 2016 revenue $155.1 million .AtriCure Inc- Preliminary and unaudited revenue for Q4 2016 is expected to be approximately $41.2 million.  Full Article

Atricure sees FY 2016 revenue up about 20 to 22 percent
Thursday, 4 Aug 2016 04:01pm EDT 

Atricure Inc : Atricure reports second quarter 2016 financial results . Sees fy 2016 revenue up about 20 to 22 percent . Q2 earnings per share view $-0.30 -- Thomson Reuters I/B/E/S . Q2 revenue $39.7 million versus i/b/e/s view $39.8 million . Q2 loss per share $0.26 .Fy2016 revenue view $160.5 million -- Thomson Reuters I/B/E/S.  Full Article

AtriCure, Inc announces $25 mln term loan
Thursday, 28 Apr 2016 04:01pm EDT 

AtriCure, Inc:Says has entered into an amended and restated term loan and revolving line of credit agreement with Silicon Valley Bank, providing access to a new $25 mln five-year term loan, as well as renewing a $15 million revolving line of credit.  Full Article

AtriCure Inc updates FY 2016 guidance
Monday, 11 Jan 2016 08:00am EST 

AtriCure Inc:Projects FY 2016 revenue growth of about 25 pct. over FY 2015 at current exchange rates.Expects FY 2016 adjusted EBITDA, a non-GAAP measure, is projected to be a loss in the range of $14 to $15 million.  Full Article

AtriCure, Inc raises FY 2015 revenue guidance; lowers FY 2015 EBITDA guidance; gives FY 2016, 2018 EBITDA guidance
Tuesday, 27 Oct 2015 04:01pm EDT 

AtriCure, Inc:Projects FY 2015 revenue will be in the range of $129.5 million to $130.5 million.Projects adjusted EBITDA, a non-GAAP measure, to be a loss in the range of $10 million to $12 million for FY 2015.Projects FY 2016 consolidated revenue growth of 25%.Projects FY 2016 adjusted EBITDA loss to increase over 2015 due to integration, commercial expansion and clinical costs resulting from the nContact transaction, with the impact slowing in 2017.Expects to be adjusted EBITDA positive for FY 2018.FY 2015 revenue of $129 million and EBITDA of $(13.4) million - Thomson Reuters I/B/E/S.FY 2016 EBITDA of $(17) million - Thomson Reuters I/B/E/S.FY 2018 EBITDA of $0.30 million - Thomson Reuters I/B/E/S.  Full Article

AtriCure Completes Acquisition of nContact
Tuesday, 13 Oct 2015 05:25pm EDT 

AtriCure, Inc:Says it has completed its previously announced acquisition of nContact, Inc., a privately held developer of innovative cardiac ablation solutions.  Full Article

AtriCure enters into definitive agreement to acquire nContact
Sunday, 4 Oct 2015 01:00pm EDT 

AtriCure:Says that it has entered into a definitive merger agreement under which AtriCure has agreed to acquire nContact, Inc., a privately held developer of innovative cardiac ablation solutions.Says transaction consideration consists of an upfront payment of approximately 3.7 million shares of AtriCure common stock, valued at $24.60 per share, and approximately $8 million in cash.  Full Article

AtriCure Inc raises FY 2015 revenue guidance; lowers high end of FY 2015 Adjusted EBITDA guidance
Tuesday, 28 Jul 2015 04:02pm EDT 

AtriCure Inc:Projects FY 2015 revenue will be in the range of $127 million to $129 million, compares to previous expectations of 2015 revenue in the range of $123.5 million to $125.5 million.Says FY 2015 Adjusted EBITDA, a non-GAAP measure, to be a loss in the range of $7 million to $8 million.FY 2015 revenue of $125 million and EBITDA of $(10) million - Thomson Reuters I/B/E/S.  Full Article

AtriCure Inc raises FY 2015 revenue guidance; reaffirms FY 2015 EBITDA guidance
Wednesday, 29 Apr 2015 04:01pm EDT 

AtriCure Inc:Projects FY 2015 revenue will be in the range of $123.5 million to $125.5 million, previous expectations in the range of $122.5 million to $124.5 million.Says Adjusted EBITDA, a non-GAAP measure, to be a loss in the range of $7 million to $9 million for FY 2015.FY 2015 revenue of $123.17 million and EBITDA of $(10) million - Thomson Reuters I/B/E/S.  Full Article

More From Around the Web

BRIEF-Atricure names two new members to its board of directors

* Regina Groves and B. Kristine Johnson have been appointed to its board of directors